SHPH Shuttle Pharmaceuticals Holdings, Inc.
Fundamentals / CIK 0001757499 / USDShuttle Pharmaceuticals Holdings, Inc. reported $22.81M in total assets and a net loss of $10.26M through December 31, 2025 from SEC EDGAR filings.
Audited annual (10-K / 20-F) and quarterly (10-Q) statements parsed directly from SEC EDGAR CompanyFacts. Open SHPH in the Convexity terminal for live prices, valuation multiples, transcripts, and insider flow.
-
Revenue FY 2025-- Dec 31, 2025
-
Operating Income FY 2025-$11.22M Operating profit
-
Net Income FY 2025-$10.26M GAAP bottom line
-
Diluted EPS FY 2025-$10.11 Split-adjusted
-
Free Cash Flow FY 2025-- Operating CF less CapEx
-
Cash & ST Investments Jun 30, 2026$90K Total debt: $195K
Annual revenue and net income
5 fiscal years (2021 to 2025), reported in USD.
Financial statements and ratios
Reported in USD. Per-share figures and share counts are adjusted for stock splits from SEC filings.
Income Statement (Annual) · Reported in USD · Newest filing period first.
| Income Statement | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 |
|---|---|---|---|---|---|
| Research & Development | $4.05M | $3.62M | $3.52M | $1.15M | $1.02M |
| Total Operating Expenses | $11.92M | $7.70M | $5.89M | $2.55M | $1.74M |
| Operating Income | -$11.92M | -$7.70M | -$5.89M | -$2.55M | -$1.74M |
| EBITDA | -$11.63M | -$7.69M | -$5.89M | -$2.55M | -$1.74M |
| Interest Income | $1.1K | $38K | $79K | -- | -- |
| Interest Expense | -- | -- | $2.12M | $918K | $3.8K |
| Income Before Tax | -- | -- | -$6.59M | -$3.03M | -$1.15M |
| Net Income | -$11.72M | -$9.14M | -$6.59M | -$3.03M | -$1.15M |
| Basic EPS | -$71.60 | -$796.50 | -$882.50 | -$580.00 | -$240.00 |
| Diluted EPS | -$71.60 | -$826.00 | -$882.50 | -$580.00 | -- |
| Basic Shares Outstanding | 163.8K | 11.5K | 7.5K | 5.2K | 4.7K |
| Diluted Shares Outstanding | 163.8K | 11.5K | 7.5K | 5.2K | -- |
Income Statement (Quarterly) · Reported in USD · Newest filing period first.
| Income Statement | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 |
|---|---|---|---|---|---|---|---|---|
| Research & Development | $56K | $267K | $512K | $943K | $1.03M | $1.57M | $986K | $1.40M |
| Total Operating Expenses | $3.95M | $2.22M | $2.79M | $2.27M | $3.91M | $2.95M | $1.78M | $3.05M |
| Operating Income | -$3.95M | -$2.22M | -$2.79M | -$2.27M | -$3.91M | -$2.95M | -$1.78M | -$3.05M |
| EBITDA | -$3.32M | -$1.58M | -- | -$2.27M | -$3.91M | -$2.95M | -$1.78M | -$3.05M |
| Interest Income | $90 | $209 | -- | $486 | $81 | -- | $3 | $2.5K |
| Net Income | -$3.15M | -$2.15M | -$2.61M | -$2.35M | -$3.71M | -$3.05M | -$1.60M | -$3.78M |
| Basic EPS | -$3.10 | -$4.30 | -- | -$10.50 | -$32.91 | -$76.00 | -- | -$398.30 |
| Diluted EPS | -$3.10 | -$4.30 | -- | -$10.50 | -$32.91 | -$76.00 | -- | -$398.30 |
| Basic Shares Outstanding | 1.0M | 503.2K | -- | 223.4K | 112.6K | 40.2K | -- | 9.5K |
| Diluted Shares Outstanding | 1.0M | 503.2K | -- | 223.4K | 112.6K | 40.2K | -- | 9.5K |
Balance Sheet (Annual) · Reported in USD · Newest filing period first.
| Balance Sheet | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 |
|---|---|---|---|---|---|
| Cash & Cash Equivalents | $334K | $1.92M | $2.58M | $8.42M | $505K |
| Short-Term Investments | -- | -- | $2.89M | -- | -- |
| Cash & Short-Term Investments | $334K | $1.92M | $5.46M | $8.42M | $505K |
| Total Current Assets | $503K | $2.21M | $5.59M | $8.58M | $510K |
| Property, Plant & Equipment, Net | $17K | $19K | $25K | $13K | $19K |
| Intangible Assets | $9.84M | -- | -- | -- | -- |
| Other Non-Current Assets | -- | -- | -- | $6.5K | -- |
| Total Non-Current Assets | $9.97M | $295K | $359K | $75K | $142K |
| Total Assets | $10.48M | $2.51M | $5.95M | $8.65M | $652K |
| Other Current Liabilities | $4.44M | -- | -- | -- | -- |
| Total Current Liabilities | $7.97M | $1.53M | $1.04M | $976K | $2.22M |
| Long-Term Debt | -- | -- | -- | -- | $91K |
| Total Non-Current Liabilities | $255K | $263K | $854K | $0 | $62K |
| Total Liabilities | $8.22M | $1.80M | $1.90M | $976K | $2.28M |
| Total Debt (incl. Leases) | $232K | $299K | $357K | $63K | $220K |
| Common Stock | $2 | $2 | $20 | $136 | $93 |
| Retained Earnings | -$46.30M | -$34.58M | -$25.43M | -$8.89M | -$5.80M |
| Total Stockholders' Equity | $2.25M | $709K | $4.06M | $7.68M | -$1.63M |
| Total Equity | $2.25M | $709K | $4.06M | $7.68M | -$1.63M |
Balance Sheet (Quarterly) · Reported in USD · Newest filing period first.
| Balance Sheet | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 |
|---|---|---|---|---|---|---|---|---|
| Cash & Cash Equivalents | $90K | $1.09M | $334K | $2.09M | $4.82M | $4.51M | $1.92M | $157K |
| Cash & Short-Term Investments | $90K | $1.09M | $334K | $2.09M | $4.82M | $4.51M | $1.92M | $157K |
| Total Current Assets | $396K | $2.46M | $503K | $3.27M | $5.19M | $4.96M | $2.21M | $361K |
| Property, Plant & Equipment, Net | $15K | $16K | $17K | $18K | $19K | $18K | $19K | $21K |
| Intangible Assets | $8.65M | $9.24M | $9.84M | -- | -- | -- | -- | -- |
| Total Non-Current Assets | $22.41M | $9.35M | $9.97M | $277K | $313K | $351K | $295K | $312K |
| Total Assets | $22.81M | $11.81M | $10.48M | $3.54M | $5.50M | $5.31M | $2.51M | $674K |
| Other Current Liabilities | -- | -- | $4.44M | -- | -- | -- | -- | -- |
| Total Current Liabilities | $3.48M | $8.31M | $7.97M | $1.96M | $1.69M | $1.78M | $1.53M | $1.66M |
| Total Non-Current Liabilities | $148K | $157K | $255K | $184K | $206K | $243K | $263K | $330K |
| Total Liabilities | $3.63M | $8.46M | $8.22M | $2.15M | $1.90M | $2.02M | $1.80M | $1.99M |
| Total Debt (incl. Leases) | $195K | $214K | $232K | $250K | $267K | $283K | $299K | $314K |
| Common Stock | $9 | $57 | $2 | $13 | $11 | $63 | $2 | $29 |
| Retained Earnings | -$51.60M | -$48.45M | -$46.30M | -$43.68M | -$41.34M | -$37.63M | -$34.58M | -$32.98M |
| Total Stockholders' Equity | $19.18M | $3.35M | $2.25M | $1.39M | $3.61M | $3.29M | $709K | -$1.32M |
| Total Equity | $19.18M | $3.35M | $2.25M | $1.39M | $3.61M | $3.29M | $709K | -$1.32M |
Cash Flow Statement (Annual) · Reported in USD · Newest filing period first.
| Cash Flow Statement | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 |
|---|---|---|---|---|---|
| Net Income | -$11.72M | -$9.54M | -$6.59M | $1.69M | -$1.15M |
| Depreciation & Amortization | $290K | $5.5K | $6.8K | $6.0K | $6.2K |
| Stock-Based Compensation | $933K | $260K | $182K | $404K | $910K |
| Change in Payables | -- | -- | -- | -$383K | $311K |
| Operating Cash Flow | -$9.48M | -$7.33M | -$5.58M | -$2.71M | -$300K |
| Capital Expenditure | -- | -- | -$19K | -- | -- |
| Free Cash Flow | -- | -- | -$5.60M | -- | -- |
| Purchases of Investments | -- | -$44K | -$3.00M | -- | -- |
| Investing Cash Flow | -$3.06M | $2.92M | -$2.83M | -- | -- |
| Common Stock Issued | -- | $3.99M | -- | $10.02M | -- |
| Financing Cash Flow | $10.95M | $3.76M | $2.57M | $10.62M | $688K |
| Net Change in Cash | -$1.59M | -$656K | -$5.84M | $7.91M | $388K |
Cash Flow Statement (Quarterly) · Reported in USD · Newest filing period first.
| Cash Flow Statement | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 |
|---|---|---|---|---|---|---|---|---|
| Net Income | -$3.15M | -$2.15M | -$2.61M | -$2.30M | -$3.80M | -$3.00M | -$1.60M | -$3.78M |
| Depreciation & Amortization | $633K | $633K | -- | $1.0K | -$979 | $1.0K | $1.8K | $793 |
| Stock-Based Compensation | -$7.5K | $35K | $215K | $134K | $47K | $537K | $32K | $45K |
| Operating Cash Flow | -$568K | -$2.42M | -$973K | -$2.63M | -$3.36M | -$2.53M | -$2.69M | -$2.00M |
| Purchases of Investments | -- | -- | -- | -- | -- | -- | $0 | -$7.6K |
| Investing Cash Flow | -$5.43M | -$36K | -- | -- | -- | -- | $0 | $1.66M |
| Common Stock Issued | $0 | $3.23M | -- | -$4.08M | $4.08M | $5.41M | -- | -- |
| Financing Cash Flow | $5.00M | $3.21M | $2.27M | -$96K | $3.66M | $5.12M | $4.45M | -$197K |
| Net Change in Cash | -$1000K | $756K | -$1.76M | -$2.72M | $305K | $2.59M | $1.76M | -$539K |
Margins, returns, leverage, liquidity, and year-over-year growth computed directly from SEC EDGAR statement levels. Multi-year figures show cumulative per-share growth.
| Ratios & Growth | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 |
|---|---|---|---|---|---|
| Return on Equity (ROE) | -519.9% | -1289.5% | -162.6% | -39.4% | -- |
| Return on Assets (ROA) | -111.9% | -364.9% | -110.8% | -35.0% | -176.8% |
| Current Ratio | 0.06x | 1.44x | 5.37x | 8.79x | 0.23x |
| Quick Ratio | 0.04x | 1.25x | 5.24x | 8.63x | 0.23x |
| Debt to Equity | 0.10x | 0.42x | 0.09x | 0.01x | -- |
Quarterly margins, ROE, and ROA use trailing-twelve-month (TTM) flows summed across four contiguous quarters. Growth rates are true year-over-year comparisons against the same quarter a year earlier.
| Ratios & Growth | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 |
|---|---|---|---|---|---|---|---|---|
| Return on Equity (ROE) | -53.5% | -323.4% | -519.9% | -767.9% | -336.8% | -318.6% | -1289.5% | -- |
| Return on Assets (ROA) | -45.0% | -91.6% | -111.9% | -302.2% | -220.6% | -197.1% | -364.9% | -1363.9% |
| Current Ratio | 0.11x | 0.30x | 0.06x | 1.66x | 3.07x | 2.78x | 1.44x | 0.22x |
| Quick Ratio | 0.03x | 0.13x | 0.04x | 1.07x | 2.85x | 2.53x | 1.25x | 0.09x |
| Debt to Equity | 0.01x | 0.06x | 0.10x | 0.18x | 0.07x | 0.09x | 0.42x | -- |